RxDoctor Payments Data

Elizabeth McQuagge, APRN

Nurse Practitioner · Ponte Vedra, FLNPI 1346852274

Payments from drug & device makers

$1,932in general payments, 2019–2025

Across 81 payments — averaging $23.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$394
  • Amgen$215
  • GSK$200
  • Merck$145
  • Atricure, Inc.$141
  • Lilly USA, LLC$136
  • plus $701 from 14 others

What the payments were for

  • Food & beverage$1,932100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,932 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$99,729
Medicare patients
515
Services billed
1,232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$25,425
JardianceEmpagliflozin21$23,268
PaxlovidNirmatrelvir/Ritonavir25$1,368
Doxycycline Hyclate69$732
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav87$722
Methylprednisolone98$688
Atorvastatin Calcium76$663
Rosuvastatin Calcium36$640
Metoprolol Succinate33$496
Omeprazole27$457
Losartan Potassium52$439
Levothyroxine Sodium50$427
Pantoprazole Sodium18$419
Gabapentin35$400
Amlodipine Besylate50$396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$120$26,79343 claims
Boehringer IngelheimJardiance$106$23,26821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Ponte Vedra

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →